Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-09-08 00:00:00 ET · period of report 2025-09-05 · accession 0001415889-25-023898 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-08 | 2025-09-05 | BBNX | Feider Stephen | CFO | S - Sale+OE | $21.00 | -100 | 44.0K | -0.2% | -$2,100 |
| D | 2025-09-08 | 2025-09-05 | BBNX | Feider Stephen | CFO | M - OptEx | $5.10 | +100 | 44.1K | +0.2% | +$510.00 |
| D | 2025-09-08 | 2025-09-05 | BBNX | Feider Stephen | CFO | M - OptEx | $0.00 | -100 | 99.6K | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-05 | S | D | 100 | $21.00 | 44,041 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-05 | M | A | 100 | $5.10 | 44,141 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-09-05 | M | D | 100 | $0.00 | 99,595 | D | $5.10 · — to 2033-09-13 | 100 Common Stock | (F2) The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. |